• Home
  • MJBA.net
  • MJNews | PRNewswire
  • CBDNews | BusinessWire
  • MJChannelOne
  • MJHeadlineNews
  • Subscribe
  • Advertise on MJNews
    • 2023 Rate Card
  • Build Your Brand

MJNews Network

"The Voice of Legal Cannabis Since 2013"

  • MJNewsNetwork.com
  • MJNews | PRNewswire
  • CBDNews | BusinessWire
  • MJ Legal
  • BlPOC in Cannabis
  • Subscribe
You are here: Home / Homepage / Nanoparticle Drones To Target Lung Cancer with Radiosensitizers And Cannabinoids

Nanoparticle Drones To Target Lung Cancer with Radiosensitizers And Cannabinoids

September 19, 2017 by MJ News Network Leave a Comment

imageWilfred Ngwa1,2*, imageRajiv Kumar1,3, imageMichele Moreau1,2, imageRaymond Dabney4 and imageAllen Herman4

1Department of Radiation Oncology, Dana-Farber Cancer Institute, Brigham and Women’s Hospital, Harvard Medical School, Boston, MA, United States
2University of Massachusetts Lowell, Lowell, MA, United States
3Northeastern University, Boston, MA, United States
4Cannabis Science Inc., Irvine, CA, United States
 
CALIFORNIA: Nanotechnology has opened up a new, previously unimaginable world in cancer diagnosis and therapy, leading to the emergence of cancer nanomedicine and nanoparticle-aided radiotherapy. Smart nanomaterials (nanoparticle drones) can now be constructed with capability to precisely target cancer cells and be remotely activated with radiation to emit micrometer-range missile-like electrons to destroy the tumor cells. These nanoparticle drones can also be programmed to deliver therapeutic payloads to tumor sites to achieve optimal therapeutic efficacy. In this article, we examine the state-of-the-art and potential of nanoparticle drones in targeting lung cancer. Inhalation (INH) (air) versus traditional intravenous (“sea”) routes of navigating physiological barriers using such drones is assessed. Results and analysis suggest that INH route may offer more promise for targeting tumor cells with radiosensitizers and cannabinoids from the perspective of maximizing damage to lung tumors cells while minimizing any collateral damage or side effects.

Introduction

Nanomedicine, the application of nanotechnology to medicine, has opened a new, previously unimaginable world in cancer diagnosis and therapy. Today new multifunctional nanoplatforms or smart nanomaterials (nanoparticle drones) can be constructed and endowed with image contrast enhancement capabilities for techniques such as computed tomography (CT) and magnetic resonance imaging (MRI) (1, 2) and can contain therapeutic payloads programmed for targeted delivery to disease sites (3). The vision of combining diagnostics and therapeutics, now being referred to as theranostics, was considered futuristic only a few years ago but is now clearly achievable—the future is almost now!

A) Cartoon showing both intravenous and inhalation (INH) delivery of nanoparticle drones; (B) TEM image of lung tumor targeted with drones; (C) absorption spectra of drone technology uniquely customized for INH delivery to lung tumors.

A) Cartoon showing both intravenous and inhalation (INH) delivery of nanoparticle drones; (B) TEM image of lung tumor targeted with drones; (C) absorption spectra of drone technology uniquely customized for INH delivery to lung tumors.

Recognizing the potential impact of nanomedicine, the National Cancer Institute created the Alliance for Cancer Nanotechnology to leverage the potential of nanotechnology toward transforming the way cancer is diagnosed, treated, or prevented. Projects funded by this Alliance have led to significant research breakthroughs and have even entered successful clinical trials (4). Today, cancer nanomedicine now includes burgeoning research and development in nanoparticle-aided radiotherapy (NRT). A recent article (5) provides a robust review of NRT developments for over a decade in NRT with gold nanoparticles (GNPs), highlighting emerging approaches, challenges, and opportunities for further research toward clinical translation. Beyond GNP, other research has highlighted the use of alternative nanoparticle platforms like gadolinium nanoparticles (6, 7), hafnium nanoparticles (8), platinum-based chemotherapy drug platforms, and others with theranostic capability (9, 10).

In general, the key goal for NRT and cancer drug development efforts is the same, which is to optimize therapeutic efficacy/ratio. To this end, recent advances in the design of smart nanomaterials proffer tremendous potential toward realizing this goal. Such smart materials (11) are specifically designed to be sensitive to a specific stimulus, such as temperature, magnetic field, ultrasound intensity, light or radiation, and pH, and to then respond in active ways including radiosensitization or changing their structure for drug delivery, or other functions that have the potential to cogently enhance treatment outcomes.

Gold nanoparticles provide an excellent template for building such nanoparticle drones. They are biocompatible radiosensitizers (5), proffering relatively no toxicity. They can readily interact with photons by the photoelectric effect, to emit missile-like photoelectrons or Auger electrons in the micrometer range, to substantially boost RT damage to cancer cells. In the photoelectric effect, photons interact with the nanomaterials, with the probability of photoelectric interaction inversely proportional to the cube of the photon energy (5). Once the photoelectron is emitted, this creates a vacancy that may be filled by an electron from a higher energy level. The resulting release of energy could then also knockout Auger electrons. The Auger electrons are shorter range and with high linear energy transfer, so can lead to highly localized damage. Such highly localized damage to tumor cells can allow minimization of the primary radiotherapy dose and hence normal tissue toxicity. Nanoplatforms such as GNPs are also particularly attractive for building nanoparticle drones because they can provide CT and photoacoustic imaging contrast and are suitable for drug loading and attaching targeting moieties. Depending on surface functionalization, type of drug, and desired application, GNPs can be easily loaded with drugs or other molecules through either non-covalent interactions or covalent conjugation. Loading of drugs onto GNPs may improve their stability and biodistribution in biological media since the drugs are protected in the carrier. In short, multifunctional nanoparticle drones based on GNPs hold great promise in cancer nanomedicine.

 

Read full article @ Frontiers

Filed Under: Homepage, Medical Tagged With: cancer nanomedicine., cannabinoids and cancer, cannabis medicine, cannabis science, cannabis technology, Cannabuniuds', cannatech, CBD, medical cannabis, medical marijuana, nanoparticle, nanoparticle drones, nanotechnology, National Cancer Institute created the Alliance for Cancer Nanotechnology, Radiosensitizers, science, the science of cannabis

About MJ News Network

Leave a Reply Cancel reply

Your email address will not be published. Required fields are marked *

Connect with Us!

  • Email
  • Facebook
  • Instagram
  • LinkedIn
  • Pinterest
  • RSS
  • Tumblr
  • Twitter
  • Vimeo
  • YouTube

Top Stories

University of Nebraska Medical Center and ANANDA Scientific announce First Patient Enrolled in FDA-approved clinical trial for Post-Traumatic Stress Disorder (PTSD)

OMAHA, Neb. & GREENWOOD VILLAGE, Colo.–(BUSINESS WIRE)–The University of Nebraska Medical Center (UNMC) and ANANDA Scientific Inc. today announced that the first patient has been enrolled in an FDA-approved clinical trial evaluating Nantheia™ ATL5, an investigational drug using cannabidiol in ANANDA’s proprietary Liquid Structure™ delivery technology, for Post-Traumatic Stress Disorder (PTSD). (Clinical Trials.gov Identifier NCT05269459) Read the full article…

New WHO Study Shows Tobacco, Alcohol and Cannabis Use Among French Adolescents Went Down During COVID-19 pandemic

FRANCE: Tobacco, alcohol and cannabis use among French adolescents has decreased in the last decade, particularly between 2018 and 2021 and following the COVID-19 outbreak in 2020, finds WHO/Europe’s collaborative Health Behaviour in School-aged Children (HBSC) study.  In France, as across the WHO European Region, measures taken to control the COVID-19 pandemic disrupted the lives Read the full article…

OPINION: The Medical Community Must Embrace Standard Cannabis Education

By Timothy Byars, Director of Cannabis Programs, Pacific College of Health and Science On July 21, 2022, Senate Majority Leader Chuck Schumer (D-NY), and Senator Cory Booker (D-NJ) filed the Cannabis Administration and Opportunity Act (CAOA), a bill that ends federal cannabis prohibition, establishes federal cannabis tax rates, expunges some cannabis convictions, and enables the Read the full article…

Oregon State Research Shows Hemp Compounds Prevent Coronavirus from Entering Human Cells

OREGON: Hemp compounds identified by Oregon State University research via a chemical screening technique invented at OSU show the ability to prevent the virus that causes COVID-19 from entering human cells. Findings of the study led by Richard van Breemen, a researcher with Oregon State’s Global Hemp Innovation Center, College of Pharmacy and Linus Pauling Institute, Read the full article…

Curt’s Cannabis Corner: Cannabis for Inflammation

Welcome to Season 2, Episode 3 in the multi-media educational series Curt’s Cannabis Corner from technical writer Curt Robbins at Higher Learning LV and MJNews Network. This series is intended for cannabis and hemp professionals—and the enterprise organizations that employ them—who wish to gain a better understanding of the nuanced biochemistry, volatile business environment, and Read the full article…

More Posts from this Category

New Jersey’s First Black Woman-Owned Medical Dispensary Obtains License to Serve Adult Use Customers

Ohio Board of Pharmacy Awards Dispensary Certificate of Operation in Sherwood

Virpax Pharmaceuticals to Present at Sidoti Virtual Investor Conference May 10-11, 2023

Tags

CA California Canada cannabis cannabis news CBD changing attitudes CO Colorado DC decriminalization dispensary District of Columbia end failed war on drugs end of failed war on drugs failed war on drugs Hemp I-502 legal cannabis legalization legal marijuana marijuana marijuana business medical cannabis medical marijuana mjlegal mjnews MJNews Network mjnewsnetwork.com mmj New York NORML NY OH Ohio OLCC OR Oregon politicians on pot recreational marijuana the business of cannabis the business of marijuana WA Washington WSLCB

Search By State:

  • Alabama
  • Alaska
  • Arizona
  • Arkansas
  • California
  • Colorado
  • Connecticut
  • Delaware
  • Florida
  • Georgia
  • Hawaii
  • Idaho
  • Illinois
  • Indiana
  • Iowa
  • Kansas
  • Kentucky
  • Louisiana
  • Maine
  • Maryland
  • Massachusetts
  • Michigan
  • Minnesota
  • Mississippi
  • Missouri
  • Montana
  • Nebraska
  • Nevada
  • New Hampshire
  • New Jersey
  • New Mexico
  • New York
  • North Carolina
  • North Dakota
  • Ohio
  • Oklahoma
  • Oregon
  • Pennsylvania
  • Rhode Island
  • South Carolina
  • South Dakota
  • Tennessee
  • Texas
  • Utah
  • Vermont
  • Virginia
  • Washington
  • West Virginia
  • Wisconsin
  • Wyoming

© Copyright 2014 MJBA Publishing · MJ News Network · All Rights Reserved ·